If you’re among the 1 in 3 people with Medicare who has diabetes, there’s some good news: starting in 2021, many participating drug plans will offer a 30-day supply of insulin for $35 or less per month through the Medicare Part D Senior Savings Model.
To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
The mechanisms of pharmaceutical rebates in Medicare Part D and commercial insurance.
Recent pharmaceutical innovations offer unprecedented possibilities for curing, treating, or preventing a range of diseases. However, patients, providers and payers alike have raised concerns about the affordability and sustainability of these drugs.